News, Updates, & Victories
KSF Obtains Final Settlement of Derivative Claims in the Matter of Exelon Corporation
On September 22, 2026, the United States District Court for the Northern District of Illinois granted final approval to a settlement agreement resolving the derivative action, under which defendants have agreed to implement various corporate reforms and make a payment of $40 million to Exelon Corporation.
Preliminary Approval of Acadia Healthcare Derivative Litigation
On September 1, 2026, the United States District Court for the Middle District of Tennessee granted preliminary approval of a settlement agreement resolving the derivative action, under which defendants have agreed to implement various corporate reforms and pay $12 million to Acadia Healthcare.
Preliminary Approval of Settlement in Acadia Pharmaceuticals Derivative Litigation
On August 24, 2026, the United States District Court for the Southern District of California granted preliminary approval of a settlement resolving the derivative action, under which defendants have agreed to implement various corporate reforms.
KSF Files a Verified Stockholder Derivative Complaint on Behalf of Medical Properties Trust
In a complaint filed on August 14, 2026 on behalf of Medical Properties Trust, plaintiff alleges, among other things, that certain of the company’s officers and directors breached their fiduciary duties, abused their control, grossly mismanaged the company, wasted corporate assets, and were unjustly enriched.
KSF Defeats Motion to Dismiss in Via Renewables, Inc. Merger Litigation
On August 12, 2026, the Delaware Court of Chancery denied defendants’ motion to dismiss a merger class action where KSF is acting as sole lead counsel.
KSF Defeats Motion to Dismiss in Substantial Part in 3M ERISA Class Action
On August 11, 2026, the United States District Court for the District of Minnesota largely denied defendants’ motion to dismiss the amended complaint in an ERISA class action.